From image to insight: How Tempus is leveraging AI to advance biomarker screening at scale

By leveraging Paige Predict to screen for genomic and phenotypic biomarkers, clinicians and researchers have rapid access to valuable information to prioritize testing and pre-screen patients at scale.

Jan 20, 2026
Providers
Article
Razik YousfiSVP & GM, Imaging, Tempus
Caitlin McWilliamsVP, Strategy & Operations, Tempus
Siqi Liu PhDVP, Machine Learning, Tempus

Related content

Simple white graphic of a single sheet of paper or document, slightly angled.Article
Light background with faint, pixelated letters resembling DNA or digital code.

The citizen scientist revolution: Empowering patient advocacy groups, patients and researchers with AI and multimodal data

Providers
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Gloved hand interacts with lab equipment amidst a luminous digital data overlay.

Closing the perception vs. reality gap in oncology care: Why accurate near real-time clinical data is vital

Providers
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Abstract blurred digital background with glowing blue and white data patterns.

Q&A: From proof of concept to clinical deployment: How foundation models are accelerating drug development

2026-05-01
Providers